Ascendis Pharma
ASND
#1252
Rank
HK$139.56 B
Marketcap
HK$2,128
Share price
-0.20%
Change (1 day)
26.38%
Change (1 year)

EPS for Ascendis Pharma (ASND)

EPS in 2026 (TTM): HK$107.20

According to Ascendis Pharma 's latest financial reports the company's current EPS (TTM) is HK$107.18. In 2025 the company made an earnings per share (EPS) of -HK$33.61 an increase over its 2024 EPS that were of -HK$55.82.

EPS history for Ascendis Pharma from 2023 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$107.20-418.98%
2025-HK$33.61-39.79%
2024-HK$55.82-23.17%
2023-HK$72.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Akebia Therapeutics
AKBA
-HK$1.26-101.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
-HK$41.01-138.26%๐Ÿ‡ฉ๐Ÿ‡ช Germany
Advaxis
ADXS.defunct
-HK$76.02-170.93%๐Ÿ‡บ๐Ÿ‡ธ USA